{"transactions":[{"id":2626566,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-23T16:52:30.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":120253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC.  In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899866-21-000076","document":"wf-form4_162707353258876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000076/wf-form4_162707353258876.xml","form_type":"4"}},{"id":2632540,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:54:28.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":29501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan."}],"balance_after":120253,"source":{"system":"sec-edgar","filing":"0000899866-21-000057","document":"wf-form4_162646885634570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000057/wf-form4_162646885634570.xml","form_type":"4"}},{"id":2632539,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:54:28.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":26812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan."}],"balance_after":90752,"source":{"system":"sec-edgar","filing":"0000899866-21-000057","document":"wf-form4_162646885634570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000057/wf-form4_162646885634570.xml","form_type":"4"}},{"id":2822830,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-03-02T17:52:49.000Z","date":"2021-02-28","kind":"grant","acquired":true,"shares":24473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":63940,"source":{"system":"sec-edgar","filing":"0000899866-21-000024","document":"wf-form4_161472555263241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000024/wf-form4_161472555263241.xml","form_type":"4"}},{"id":2938545,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:04:14.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":2510,"price":157.96,"value":396479.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":39467,"source":{"system":"sec-edgar","filing":"0000899866-20-000092","document":"wf-form4_160832903829817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000092/wf-form4_160832903829817.xml","form_type":"4"}},{"id":2938544,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:04:14.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":6853,"price":157.96,"value":1082499.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."}],"balance_after":41977,"source":{"system":"sec-edgar","filing":"0000899866-20-000092","document":"wf-form4_160832903829817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000092/wf-form4_160832903829817.xml","form_type":"4"}},{"id":2938543,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:04:14.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":15371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan."}],"balance_after":48830,"source":{"system":"sec-edgar","filing":"0000899866-20-000092","document":"wf-form4_160832903829817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000092/wf-form4_160832903829817.xml","form_type":"4"}},{"id":2963490,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-01T17:17:08.000Z","date":"2020-11-30","kind":"tax_withholding","acquired":false,"shares":1298,"price":124,"value":160952.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":33459,"source":{"system":"sec-edgar","filing":"0000899866-20-000089","document":"wf-form4_160686101427825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000089/wf-form4_160686101427825.xml","form_type":"4"}},{"id":3234983,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:20:12.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":883,"price":90.54,"value":79946.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.48 - $92.38.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":34757,"source":{"system":"sec-edgar","filing":"0000899866-20-000020","document":"wf-form4_158327759431214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000020/wf-form4_158327759431214.xml","form_type":"4"}},{"id":3234982,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:20:12.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":10880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":35640,"source":{"system":"sec-edgar","filing":"0000899866-20-000020","document":"wf-form4_158327759431214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000020/wf-form4_158327759431214.xml","form_type":"4"}},{"id":3353131,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-12-04T18:36:50.000Z","date":"2019-12-02","kind":"tax_withholding","acquired":false,"shares":5441,"price":113.2,"value":615921.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $113.20 - $114.00.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":24760,"source":{"system":"sec-edgar","filing":"0000899866-19-000103","document":"wf-form4_157550259239392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000103/wf-form4_157550259239392.xml","form_type":"4"}},{"id":3480565,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Business Off"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-06-24T16:45:33.000Z","date":"2019-06-21","kind":"sale","acquired":false,"shares":578,"price":132,"value":76296.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":30201,"source":{"system":"sec-edgar","filing":"0000899866-19-000078","document":"wf-form4_156140911872892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000078/wf-form4_156140911872892.xml","form_type":"4"}},{"id":3515692,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Director"}}],"security":"Common Stock","published_at":"2019-05-22T20:33:28.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":12382,"price":8.48,"value":104999.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors."}],"balance_after":16865,"source":{"system":"sec-edgar","filing":"0001593968-19-001162","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000159396819001162/primary_01.xml","form_type":"4"}},{"id":3536643,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Director"}}],"security":"Common Stock","published_at":"2019-05-07T20:19:31.000Z","date":"2019-05-06","kind":"tax_withholding","acquired":false,"shares":1661,"price":9.8825,"value":16414.8325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Withholding of shares to pay the tax liability associated with vesting of restricted shares"}],"balance_after":4483,"source":{"system":"sec-edgar","filing":"0001593968-19-001055","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000159396819001055/primary_01.xml","form_type":"4"}},{"id":3615637,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Business Off"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-05T20:23:14.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":30779,"source":{"system":"sec-edgar","filing":"0000899866-19-000051","document":"wf-form4_155183538033538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000051/wf-form4_155183538033538.xml","form_type":"4"}},{"id":3620736,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy & Business Off"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-04T17:45:59.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":267,"price":132.92,"value":35489.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.90- $134.75.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":22529,"source":{"system":"sec-edgar","filing":"0000899866-19-000043","document":"wf-form4_155173954522827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000043/wf-form4_155173954522827.xml","form_type":"4"}},{"id":3939250,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-05-10T20:30:49.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":6144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 6, 2019.  Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 6, 2019.  Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors."}],"balance_after":6144,"source":{"system":"sec-edgar","filing":"0001209784-18-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000120978418000022/edgar.xml","form_type":"4"}},{"id":4079689,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":137090,"kind":"person","name":"SARIN ARADHANA","position":1,"cik":"0001729110","reported_name":"SARIN ARADHANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock options","published_at":"2018-02-02T21:29:15.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date.  Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date.  Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":21.885,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209784-18-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000120978418000003/edgar.xml","form_type":"4"}}]}